Continuous Long-Term Entecavir Therapy in Naïve Chronic Hepatitis B Patients Showing Partial Virologic Response-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Continuous Long-Term Entecavir Therapy in Naïve Chronic Hepatitis B Patients Showing Partial Virologic Response

Published:2013-11-15 Issue:6 Volume:7 Page:712-718
ISSN:1976-2283
Container-title:Gut and Liver
language:en
Short-container-title:Gut Liver

Author:

Kwon Dae Hun,Kim In Hee,Choung Bum Su,Ahn Dae Seon,Yoo Sun Ho,Park Sang Bae,Lee Seok,Kim Seong Hun,Kim Sang Wook,Im Yong Jin

Publisher

The Editorial Office of Gut and Liver

Subject

Gastroenterology,Hepatology

Link

http://pdf.medrang.co.kr/GNL/2013/007/gnl-7-712.pdf

Reference18 articles.

1. EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection

2. KASL Clinical Practice Guidelines: Management of chronic hepatitis B

3. Management of treatment failure in chronic hepatitis B

4. Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy

5. Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tenofovir monotherapy versus tenofovir plus entecavir combination therapy in HBeAg‐positive chronic hepatitis patients with partial virological response to entecavir;Journal of Medical Virology;2019-10-29

2. Efficacy of long-term tenofovir disoproxil fumarate therapy in chronic hepatitis B patients with partial virologic response in real practice;The Korean Journal of Internal Medicine;2019-07-01

3. Switching to tenofovir vs continuing entecavir for hepatitis B virus with partial virologic response to entecavir: a randomized controlled trial;Journal of Viral Hepatitis;2018-06-06

4. On-treatment HBV DNA dynamics predict virological breakthrough in entecavir-treated HBeAg-positive chronic hepatitis B;PLOS ONE;2017-03-28

5. KASL clinical practice guidelines: management of chronic hepatitis B;Clinical and Molecular Hepatology;2016-03-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3